Fed. Circ. Urged To Upend Actavis' $12M Legal Fee Deduction
The Federal Circuit should reverse a decision allowing drugmaker Actavis to deduct as regular business expenses $12 million it spent fighting lawsuits as it tried to secure approval to sell generic...To view the full article, register now.
Already a subscriber? Click here to view full article